Alberta Research to Spot Early Stage Lung Cancer

alberta research to spot early stage lung cancer

Earlier and faster cancer detection is underway in Alberta

david wishart genome alberta biomark diagnostics

Mikenomics  | April 6, 2021

Earlier and faster cancer detection is the goal of research underway here in Alberta.​With funding from the Spark GrantsThe Metabolomics Innovation Centre (TMIC) based at the University of Alberta is leading the new effort.

With funding from the Spark GrantsThe Metabolomics Innovation Centre (TMIC) based at the University of Alberta is leading the new effort. Too often cancer is detected at a late stage but when lung cancers are treated early, survival rates increase significantly. TMIC co-director David Wishart’s team could transform lung cancer detection and save lives with a metabolomics-based blood test which would improve treatment outcomes enormously.

When things go wrong with our body, early warning signs include changes to the metabolites found in blood and urine. Match those early metabolomic changes with the disease, and clinicians will gain an important diagnostic advantage.

Genome Alberta has been supporting the work of David Wishart and TMIC for years because of the promise of metabolomics and we are pleased to see organizations such as the Canadian Cancer Society, CIHR, and Brain Canada provide new funding for this important field of study. Freelance broadcaster Don Hill talked with David Wishart about the role of metabolomics in detecting disease and his latest work to put it to use in early cancer detection.

 LISTEN TO PODCAST

Source: https://genomealberta.ca/genomics/genomics_blog_04062101.aspx

Share this post:
Share on facebook
Share on twitter
Share on linkedin
Share on email
Categories
Archives

Sign up for the latest Biomark news

No paperwork, no hassle. We keep things digital, easy and regular.

*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.

BioMark Diagnostics Inc.
CSE: BUX
OTC: BMKDF
FSE: 20B
Investors

Related articles ...

© 2021 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.